-
Rapid Detection & Differentiation of SARS-CoV-2, FLU A or B
-
Accurate Results Within 15 Minutes
-
Uses BD Veritor Analyzer to Analyze and Display Results
-
Advanced Particle Technology for Enhanced Sensitivity
-
Adaptive Read Technology for Increased Specificity
-
Reduces Instances of False Positives
-
FDA EUA, Pending FDA Clearance
-
Shelf Life: 485 Days .

The BD Veritor SARS-CoV-2 & Influenza A+B Rapid Detection Kit (30/kit) tests for three respiratory viruses (SARS-CoV-2 & Flu A, and Flu B) with just one nasal specimen. This rapid test requires the BD Veritor Plus Analyzer (sold separately) and Upgrade Key for analysis.
✔ Detects 3 Viruses in One Specimen | ✔ Results in 15 Minutes | ✔ EUA-Authorized
STREAMLINED WORKFLOW, FASTER TURNAROUND
EASY SAMPLE COLLECTION: Uses a simple nasal swab inserted into the provided extraction reagent. The specimen is mixed and added directly to the test device with minimal steps.
AUTOMATED READOUT: After 15 minutes, the device is inserted into the BD Veritor™ Analyzer for clear digital results — no subjective line interpretation.
ON-SITE VIRUS IDENTIFICATION: Helps determine the exact infection before the patient leaves the facility, improving care and isolation decisions.
PUBLIC HEALTH IMPACT: Faster identification supports contact tracing and outbreak containment.
ADVANCED DIGITAL ANTIGEN DETECTION
TRIPLE-VIRUS DIFFERENTIATION: Detects and distinguishes SARS-CoV-2, Influenza A, and Influenza B in a single test run.
PRECISION PARTICLE TECHNOLOGY: Antigen–antibody binding with detector particles ensures reliable detection on the reaction membrane.
CONTROL & TEST VALIDATION: “C” and “T” positions confirm internal control and positive targets for accurate interpretation.
REDUCED HUMAN ERROR: Analyzer-driven interpretation eliminates guesswork and faint-line uncertainty.
FDA Disclaimer: This combination test is not FDA cleared or approved, but only authorized under an Emergency Use Authorization for use by authorized laboratories. It is authorized for the rapid detection of proteins from SARS-CoV-2, Influenza A & Influenza B and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.